Sufentanil limits the myocardial infarct size by preservation of the phosphorylated connexin 43

International Immunopharmacology

Volumn 13, Issue 3, 2012, Pages 341-346

  Wu, Yun ^a   Gu, Er Wei ^a   Zhu, Yan ^a   Zhang, Lei ^a   Liu, Xun Qin ^a   Fang, Wei Ping ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Analgesia; Cardioprotection; Myocardial infarct; Sufentanil

Indexed keywords

CONNEXIN 43; SUFENTANIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HEART INFARCTION; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART ISCHEMIC REPERFUSION INJURY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; ISCHEMIC PRECONDITIONING; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; REPERFUSION INJURY; SHAM PROCEDURE; THERAPY EFFECT; WESTERN BLOTTING;

ANIMALS; CARDIOTONIC AGENTS; CONNEXIN 43; ISCHEMIC POSTCONDITIONING; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; SUFENTANIL;

EID: 84861477072     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2012.04.009     Document Type: Article

References (45)

1. Zhao ZQ, Corvera JS, Halkos ME, Kerendi F, Wang NP, Guyton RA, et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 2003;285: H579-88. (Pubitemid 36885888)
2. Yellon DM, Opie LH. Postconditioning for protection of the infracting heart. Lancet 2006;367:456-8.
3. Chiari PC, Bienengraeber MW, Pagel PS, Krolikowski JG, Kersten JR, Warltier DC. Isoflurane protects against myocardial infarction during early reperfusion by activation of phosphatidylinositol-3-kinase signal transduction: evidence for anesthetic-induced postconditioning in rabbits. Anesthesiology 2005;102:102-9. (Pubitemid 40082846)
4. Lucchinetti E, Ambrosio S, Aguirre J, Herrmann P, Härter L, Keel M, et al. Sevoflurane inhalation at sedative concentrations provides endothelial protection against ischemia-reperfusion injury in humans. Anesthesiology 2007;106:262-8. (Pubitemid 46185170)
5. Lu J, Zang WJ, Yu XJ, Jia B, Chorvatova A, Sun L. Effects of postconditioning of adenosine and acetylcholine on the ischemic isolated rat ventricular myocytes. Eur J Pharmacol 2006;549:133-9. (Pubitemid 44441269)
6. Chen Z, Li T, Zhang B. Morphine postconditioning protects against reperfusion injury in the isolated rat hearts. J Surg Res 2008;145:287-94.
7. Wong GT, Li R, Jiang LL, Irwin MG. Remifentanil post-conditioning attenuates cardiac ischemia-reperfusion injury via kappa or delta opioid receptor activation. Acta Anaesthesiol Scand 2010;54:510-8.
8. Severs NJ, Coppen SR, Dupont E, Yeh HI, Ko YS, Matsushita T. Gap junction alterations in human cardiac disease. Cardiovasc Res 2004;62:368-77. (Pubitemid 38496549)
9. Shintani-Ishida K, Unuma K, Yoshida K. Ischemia enhances translocation of connexin43 and gap junction intercellular communication, thereby propagating contraction band necrosis after reperfusion. Circ J 2009;73:1661-8.
10. Minamino T. Gap junctions mediate the spread of ischemia-reperfusion injury. Circ J 2009;73:1591-2.
11. García-Dorado D, Rodríguez-Sinovas A, Ruiz-Meana M. Gap junction-mediated spread of cell injury and death during myocardial ischemia-reperfusion. Cardiovasc Res 2004;61:386-401. (Pubitemid 38210146)
12. Sosinsky GE, Nicholson BJ. Structural organization of gap junction channels. Biochim Biophys Acta 2005;1711:99-125.
13. Solan JL, Lampe PD. Connexin43 phosphorylation: structural changes and biological effects. Biochem J 2009;419:261-72.
14. Beyer EC, Paul DL, Goodenough DA. Connexin43: a protein from rat heart homologous to a gap junction protein from liver. J Cell Biol 1987;105:2621-9. (Pubitemid 18017692)
15. Jain SK, Schuessler RB, Saffitz JE. Mechanisms of delayed electrical uncoupling induced by ischemic preconditioning. Circ Res 2003;92:1138-44. (Pubitemid 36665860)
16. Schulz R, Heusch G. Connexin43 and ischemic preconditioning. Adv Cardiol 2006;42:213-27. (Pubitemid 43805866)
17. Kin H, Zhao ZQ, Sun HY, Wang NP, Corvera JS, Halkos ME, et al. Postconditioning attenuates myocardial ischemia-reperfusion injury by inhibiting events in the early minutes of reperfusion. Cardiovasc Res 2004;62:74-85. (Pubitemid 38326813)
18. Yu CK, Li YH, Wong GT, Wong TM, Irwin MG. Remifentanil preconditioning confers delayed cardioprotection in the rat. Br J Anaesth 2007;99:632-8. (Pubitemid 351773220)
19. Totzeck A, Boengler K, van de Sand A, Konietzka I, Gres P, Garcia-Dorado D, et al. No impact of protein phosphatases on connexin 43 phosphorylation in ischemic preconditioning. Am J Physiol Heart Circ Physiol 2008;295:H2106-12.
20. Nagy JI, Li WE, Roy C, Doble BW, Gilchrist JS, Kardami E, et al. Selective monoclonal antibody recognition and cellular localization of an unphosphorylated form of connexin43. Exp Cell Res 1997;236:127-36. (Pubitemid 27452356)
21. Xue FS, Liu KP, Liu Y, Xu YC, Liao X, Zhang GH, et al. Assessment of small-dose fentanyl and sufentanil blunting the cardiovascular responses to laryngoscopy and intubation in children. Paediatr Anaesth 2007;17:568-74. (Pubitemid 46718177)
22. Dabrowska-Wójciak I, Piotrowski A. New opioids for general anaesthesia and in- and out-hospital analgesia. Anestezjol Intens Ter 2008;40:39-43.
23. Gross ER, Peart JN, Hsu AK, Auchampach JA, Gross GJ. Extending the cardioprotective window using a novel delta-opioid agonist fentanyl isothiocyanate via the PI3-kinase pathway. Am J Physiol Heart Circ Physiol 2005;288:H2744-9. (Pubitemid 40720653)
24. Piper HM, Abdallah Y, Schäfer C. The first minutes of reperfusion: a window of opportunity for cardioprotection. Cardiovasc Res 2004;61:365-71. (Pubitemid 38210144)
25. Chakrabarti S, Chang A, Gintzler AR. Subcellular localization of mu-opioid receptor G(s) signaling. J Pharmacol Exp Ther 2010;333:193-200.
26. Tuncer S, Barişkaner H, Yosunkaya A, Kiliç M, Doǧan N, Otelcioǧlu S. The effects of sufentanil and remifentanil in the isolated perfused rat kidney. Agri 2004;16: 56-61. (Pubitemid 38620502)
27. Beyer EC, Kistler J, Paul DL, Goodenough DA. Antisera directed against connexin43 peptides react with a 43-kD protein localized to gap junctions in myocardium and other tissues. J Cell Biol 1989;108:595-605. (Pubitemid 19065855)
28. van Veen AA, van Rijen HV, Opthof T. Cardiac gap junction channels: modulation of expression and channel properties. Cardiovasc Res 2001;51:217-29. (Pubitemid 32695532)
29. Kwak BR, Jongsma HJ. Regulation of cardiac gap junction channel permeability and conductance by several phosphorylating conditions. Mol Cell Biochem 1996;157:93-9. (Pubitemid 26142441)
30. Burt JM, Spray DC. Inotropic agents modulate gap junctional conductance between cardiac myocytes. Am J Physiol 1988;254:H1206-10.
31. Lau AF, Hatch-Pigott V, Crow DS. Evidence that heart connexin43 is a phosphoprotein. J Mol Cell Cardiol 1991;23:659-63.
32. + through gap junctions. Circ Res 1999;85:280-7.
33. Miura T, Yano T, Naitoh K, Nishihara M, Miki T, Tanno M, et al. Delta-opioid receptor activation before ischemia reduces gap junction permeability in ischemic myocardium by PKC-epsilon-mediated phosphorylation of connexin 43. Am J Physiol Heart Circ Physiol 2007;293:H1425-31. (Pubitemid 47367185)
34. Garcia-Dorado D, Inserte J, Ruiz-Meana M, González MA, Solares J, Juliá M, et al. Gap junction uncoupler heptanol prevents cell-to-cell progression of hypercontracture and limits necrosis during myocardial reperfusion. Circulation 1997;96:3579-86. (Pubitemid 27513436)
35. Miura T, Ohnuma Y, Kuno A, Tanno M, Ichikawa Y, Nakamura Y, et al. Protective role of gap junctions in preconditioning against myocardial infarction. Am J Physiol Heart Circ Physiol 2004;286:H214-21. (Pubitemid 38049482)
36. Rodríguez-Sinovas A, García-Dorado D, Ruiz-Meana M, Tanno M, Ichikawa Y, Nakamura Y, et al. Protective effect of gap junction uncouplers given during hypoxia against reoxygenation injury in isolated rat hearts. Am J Physiol Heart Circ Physiol 2006;290:H648-56.
37. Kwak BR, Jonqsma HJ. Regulation of cardiac gap junction channel permeability and conductance by several phosphorylating conditions. Mol Cell Biochem 1996;157:93-9. (Pubitemid 26142441)
38. Laird DW. Connexin phosphorylation as a regulatory event linked to gap junction internalization and degradation. Biochim Biophys Acta 2005;1711:172-82.
39. Lampe PD, Lau AF. Regulation of gap junctions by phosphorylation of connexins. Arch Biochem Biophys 2000;384:205-15. (Pubitemid 32012794)
40. Moreno AP, Lau AF. Gap junction channel gating modulated through protein phosphorylation. Prog Biophys Mol Biol 2007;94:107-19. (Pubitemid 46782982)
41. Schulz R, Heusch G. Connexin 43 and ischemic preconditioning. Cardiovasc Res 2004;62:335-44. (Pubitemid 38496546)
42. Solan JL, Lampe PD. Connexin phosphorylation as a regulatory event linked to gap junction channel assembly. Biochim Biophys Acta 2005;1711:154-63.
43. Penna C, Mancardi D, Raimondo S, Geuna S, Pagliaro P. The paradigm of postconditioning to protect the heart. J Cell Mol Med 2008;12:435-58.
44. Zatta AJ, Kin H, Lee G, Wang N, Jiang R, Lust R, et al. Infarct-sparing effect of myocardial postconditioning is dependent on protein kinase C signalling. Cardiovasc Res 2006;70:315-24.
45. Lemoine S, Puddu PE, Durand C, Lepage O, Babatasi G, Ivascau C. Signaling pathways involved in postconditioning-induced cardioprotection of human myocardium, in vitro. Exp Biol Med (Maywood) 2010;235:768-76.